Fengsong Wang

Dr. Fengsong Wang


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2018 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
XCXueran Chen
Xueran Chen
SZShangrong Zhang
Shangrong Zhang
ZWZhen Wang
Zhen Wang
FWFengsong Wang
Fengsong Wang
XCXinwang Cao
Xinwang Cao
ZFZhiyou Fang
Zhiyou Fang
Background: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world and metastasis is the leading cause of death associated with HCC. Hypoxia triggers the epithelial-mesenchymal transition (EMT) of cancer cells, which enhances their malignant character and elevates metastatic risk. Supervillin associates tightly with the membrane and cytoskeleton, promoting cell motility, invasiveness, and cell survival. However, the roles of supervillin in HCC metastasis remain unclear. Methods: Tissue microarray technology was used to immunohistochemically stain for supervillin antibody in 173 HCC tissue specimens and expression levels correlated with the clinicopathological variables. Tumor cell motility and invasiveness, as well as changes in the mRNA expression levels of genes associated with cancer cell EMT, were investigated. The relationship between supervillin and Rho GTPases was examined using Co-IP and GST pull-down. Results: Hypoxia-induced upregulation of supervillin promoted cancer cell migration and invasion via the activation of the ERK/p38 pathway downstream of RhoA/ROCK signaling. Furthermore, supervillin regulated the expression of EMT genes during hypoxia and accelerated the metastasis of HCC in vivo. Conclusions: Hypoxia-induced increase in supervillin expression is a significant and independent predictor of cancer metastasis, which leads to poor survival in HCC patients. Our results suggest that supervillin may be a candidate prognostic factor for HCC and a valuable target for therapy.

22 October 2019 in Journal of Molecular Cell Biology
Verified
Journal Article
Open access
XSXiaoyu Song
Xiaoyu Song
WWWanjuan Wang
Wanjuan Wang
HWHaowei Wang
Haowei Wang
XYXiao Yuan
Xiao Yuan
FYFengrui Yang
Fengrui Yang
XLXing Liu
Xing Liu
Ezrin, a membrane–cytoskeleton linker protein, plays an essential role in cell polarity establishment, cell migration, and division. Recent studies show that ezrin phosphorylation regulates breast cancer metastasis by promoting cancer cell survivor and promotes intrahepatic metastasis via cell migration. However, it was less characterized whether there are additional post-translational modifications and/or post-translational crosstalks on ezrin underlying context-dependent breast cancer cell migration and invasion. Here we show that ezrin is acetylated by p300/CBP-associated factor (PCAF) in breast cancer cells in response to CCL18 stimulation. Ezrin physically interacts with PCAF and is a cognate substrate of PCAF. The acetylation site of ezrin was mapped by mass spectrometric analyses, and dynamic acetylation of ezrin is essential for CCL18-induced breast cancer cell migration and invasion. Mechanistically, the acetylation reduced the lipid-binding activity of ezrin to ensure a robust and dynamic cycling between the plasma membrane and cytosol in response to CCL18 stimulation. Biochemical analyses show that ezrin acetylation prevents the phosphorylation of Thr567. Using atomic force microscopic measurements, our study revealed that acetylation of ezrin induced its unfolding into a dominant structure, which prevents ezrin phosphorylation at Thr567. Thus, these results present a previously undefined mechanism by which CCL18-elicited crosstalks between the acetylation and phosphorylation on ezrin control breast cancer cell migration and invasion. This suggests that targeting PCAF signaling could be a potential therapeutic strategy for combating hyperactive ezrin-driven cancer progression.

2 December 2021 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
MXMingfei Xiang
Mingfei Xiang
YWYu Wang
Yu Wang
WXWeilong Xu
Weilong Xu
NZNa Zheng
Na Zheng
HDHongshi Deng
Hongshi Deng
FZFuxi Zhu
Fuxi Zhu

23 January 2021 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
MLMengmeng Lu
Mengmeng Lu
SKShuai Kong
Shuai Kong
MXMingfei Xiang
Mingfei Xiang
YWYu Wang
Yu Wang
JZJingjing Zhang
Jingjing Zhang
FZFuxi Zhu
Fuxi Zhu

22 June 2021 in Reproductive Sciences
Verified
Journal Article
Closed access
PDF file
MXMingfei Xiang
Mingfei Xiang
YWYu Wang
Yu Wang
KWKe Wang
Ke Wang
SKShuai Kong
Shuai Kong
MLMengmeng Lu
Mengmeng Lu
FZFuxi Zhu
Fuxi Zhu

18 August 2021 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
MXMingfei Xiang
Mingfei Xiang
YWYu Wang
Yu Wang
WXWeilong Xu
Weilong Xu
NZNa Zheng
Na Zheng
JZJingjing Zhang
Jingjing Zhang
FZFuxi Zhu
Fuxi Zhu